Financial Toxicity and Shared Decision Making in Oncology

Rachel A Greenup

doi:10.1016/j.soc.2021.08.001

Financial Toxicity and Shared Decision Making in Oncology

Surg Oncol Clin N Am. 2022 Jan;31(1):1-7. doi: 10.1016/j.soc.2021.08.001. Epub 2021 Oct 19.

Author

Rachel A Greenup¹

Affiliation

¹ Division of Surgical Oncology, Department of Surgery, Yale University School of Medicine, 310 Cedar Street, LH 118, New Haven, CT 60510, USA; The Breast Center at Smilow Cancer Hospital at Yale New Haven, New Haven, CT 06511, USA. Electronic address: rachel.greenup@yale.edu.

PMID: 34776059
DOI: 10.1016/j.soc.2021.08.001

Abstract

Oncologists are often ill-prepared for patient-provider communication about the financial costs and burden of treatment. Several barriers to cost communication exist, including provider discomfort, lack of knowledge or access to accurate information, and background historic concerns that cost discussions may negatively impact the doctor-patient relationship. However, clear and transparent cost communication can yield cost-reducing strategies that ultimately mitigate the high costs of cancer care and risk for financial toxicity.

Keywords: Cancer; Disparities; Financial toxicity; Shared decision making.

Publication types

Review

MeSH terms

Decision Making
Decision Making, Shared
Financial Stress
Humans
Medical Oncology
Neoplasms* / therapy
Oncologists*
Physician-Patient Relations